Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| HIV Antibodies | 5 | 2019 | 776 | 1.09 | Why? |
| Antibodies, Neutralizing | 16 | 2021 | 25288 | 0.95 | Why? |
| HIV-1 | 5 | 2019 | 3365 | 0.88 | Why? |
| Antibodies, Bispecific | 3 | 2018 | 207 | 0.75 | Why? |
| Nucleocapsid | 1 | 2020 | 734 | 0.60 | Why? |
| Protein Engineering | 1 | 2018 | 536 | 0.58 | Why? |
| Antibodies, Viral | 17 | 2021 | 51949 | 0.56 | Why? |
| Spike Glycoprotein, Coronavirus | 16 | 2021 | 37182 | 0.51 | Why? |
| Antibodies, Monoclonal | 9 | 2021 | 8041 | 0.48 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2020 | 1267 | 0.47 | Why? |
| Neutralization Tests | 12 | 2021 | 6698 | 0.47 | Why? |
| Membrane Glycoproteins | 7 | 2021 | 2273 | 0.46 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.42 | Why? |
| Retroviridae Proteins | 1 | 2008 | 5 | 0.38 | Why? |
| Viral Envelope Proteins | 6 | 2020 | 3539 | 0.34 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2013 | 533 | 0.33 | Why? |
| Vaccines, DNA | 5 | 2017 | 871 | 0.32 | Why? |
| Vaccinia virus | 2 | 2007 | 346 | 0.31 | Why? |
| HIV Infections | 4 | 2019 | 11620 | 0.30 | Why? |
| CD4 Antigens | 2 | 2018 | 306 | 0.28 | Why? |
| Myocytes, Cardiac | 2 | 2021 | 804 | 0.28 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 2 | 2018 | 386 | 0.28 | Why? |
| Basketball | 2 | 2021 | 60 | 0.27 | Why? |
| HEK293 Cells | 7 | 2021 | 8394 | 0.27 | Why? |
| Promoter Regions, Genetic | 1 | 2008 | 823 | 0.27 | Why? |
| Organoids | 2 | 2020 | 840 | 0.26 | Why? |
| Virus Replication | 4 | 2021 | 14331 | 0.26 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.23 | Why? |
| Presenilin-2 | 1 | 2021 | 8 | 0.23 | Why? |
| Presenilin-1 | 1 | 2021 | 17 | 0.23 | Why? |
| Amyloid Precursor Protein Secretases | 1 | 2021 | 38 | 0.22 | Why? |
| Cryoelectron Microscopy | 4 | 2021 | 2372 | 0.21 | Why? |
| Cloning, Molecular | 3 | 2021 | 1036 | 0.21 | Why? |
| Sulfonic Acids | 1 | 2021 | 205 | 0.21 | Why? |
| Receptors, Virus | 6 | 2021 | 5659 | 0.21 | Why? |
| Models, Molecular | 5 | 2021 | 7616 | 0.20 | Why? |
| Immunoglobulin Variable Region | 1 | 2021 | 253 | 0.20 | Why? |
| Turbinates | 1 | 2021 | 205 | 0.20 | Why? |
| Camelids, New World | 1 | 2021 | 276 | 0.20 | Why? |
| Molecular Probes | 1 | 2020 | 106 | 0.20 | Why? |
| Epitope Mapping | 2 | 2020 | 1240 | 0.20 | Why? |
| Tropism | 1 | 2020 | 210 | 0.19 | Why? |
| Animals | 18 | 2021 | 78931 | 0.19 | Why? |
| Chemokine CCL2 | 1 | 2021 | 389 | 0.19 | Why? |
| Drug Evaluation, Preclinical | 2 | 2021 | 3347 | 0.19 | Why? |
| AIDS Vaccines | 2 | 2017 | 452 | 0.19 | Why? |
| Berlin | 1 | 2019 | 283 | 0.18 | Why? |
| Haplorhini | 1 | 2019 | 307 | 0.18 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.18 | Why? |
| Dependovirus | 1 | 2019 | 272 | 0.17 | Why? |
| Vero Cells | 5 | 2021 | 14117 | 0.17 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.17 | Why? |
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 95 | 0.16 | Why? |
| Pyrrolidines | 1 | 2021 | 558 | 0.16 | Why? |
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2017 | 203 | 0.16 | Why? |
| Organ Specificity | 1 | 2020 | 1070 | 0.15 | Why? |
| Macaca mulatta | 2 | 2021 | 3716 | 0.15 | Why? |
| Colon | 1 | 2020 | 669 | 0.14 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2020 | 584 | 0.14 | Why? |
| Cysteine Proteinase Inhibitors | 1 | 2021 | 675 | 0.14 | Why? |
| Heart Injuries | 1 | 2021 | 608 | 0.14 | Why? |
| Drug Resistance, Viral | 1 | 2021 | 1083 | 0.14 | Why? |
| Single-Domain Antibodies | 1 | 2021 | 744 | 0.13 | Why? |
| Chromatography, Gel | 1 | 2013 | 71 | 0.13 | Why? |
| Protein Domains | 3 | 2021 | 6563 | 0.13 | Why? |
| Crystallography, X-Ray | 1 | 2021 | 2689 | 0.13 | Why? |
| SARS Virus | 6 | 2007 | 13021 | 0.13 | Why? |
| Recombinant Fusion Proteins | 1 | 2018 | 919 | 0.13 | Why? |
| Mutation | 6 | 2021 | 12376 | 0.12 | Why? |
| Protein Conformation | 2 | 2021 | 4386 | 0.12 | Why? |
| Macrophages | 2 | 2021 | 2784 | 0.12 | Why? |
| Surface Plasmon Resonance | 1 | 2013 | 440 | 0.11 | Why? |
| HIV Envelope Protein gp120 | 1 | 2013 | 267 | 0.11 | Why? |
| Mice | 9 | 2021 | 21357 | 0.10 | Why? |
| HIV | 1 | 2017 | 1116 | 0.10 | Why? |
| Inhibitory Concentration 50 | 1 | 2013 | 907 | 0.10 | Why? |
| Pluripotent Stem Cells | 2 | 2021 | 167 | 0.10 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.10 | Why? |
| Nanoparticles | 1 | 2021 | 2040 | 0.10 | Why? |
| Humans | 31 | 2021 | 930598 | 0.10 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.10 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.10 | Why? |
| Gene Products, tat | 1 | 2008 | 7 | 0.09 | Why? |
| Gene Products, pol | 1 | 2008 | 13 | 0.09 | Why? |
| Gene Products, nef | 1 | 2008 | 15 | 0.09 | Why? |
| Gene Products, gag | 1 | 2008 | 28 | 0.09 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.09 | Why? |
| Antigens, Viral | 3 | 2020 | 6298 | 0.09 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2017 | 4545 | 0.09 | Why? |
| Cell Line | 5 | 2021 | 12040 | 0.09 | Why? |
| Gene Products, env | 1 | 2008 | 74 | 0.09 | Why? |
| Carboxypeptidases | 2 | 2005 | 148 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.09 | Why? |
| Protein Structure, Tertiary | 3 | 2007 | 1565 | 0.08 | Why? |
| Biological Products | 1 | 2020 | 2331 | 0.08 | Why? |
| Blotting, Western | 1 | 2008 | 863 | 0.07 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.07 | Why? |
| Adenoviruses, Human | 1 | 2007 | 195 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 7868 | 0.07 | Why? |
| Transfection | 1 | 2008 | 864 | 0.07 | Why? |
| Rabbits | 2 | 2007 | 1171 | 0.07 | Why? |
| Virus Internalization | 5 | 2021 | 7921 | 0.07 | Why? |
| Plasmids | 1 | 2008 | 840 | 0.07 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.07 | Why? |
| Spleen | 1 | 2008 | 877 | 0.07 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Cricetinae | 2 | 2021 | 3344 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Protein Binding | 4 | 2021 | 11430 | 0.06 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.06 | Why? |
| Male | 11 | 2021 | 367725 | 0.06 | Why? |
| Adult | 6 | 2021 | 244371 | 0.06 | Why? |
| Immunization | 2 | 2008 | 2019 | 0.06 | Why? |
| Lung | 2 | 2020 | 31049 | 0.06 | Why? |
| Cross Reactions | 2 | 2017 | 4374 | 0.06 | Why? |
| Biotinylation | 1 | 2020 | 55 | 0.06 | Why? |
| Female | 10 | 2021 | 380317 | 0.05 | Why? |
| Aged | 4 | 2021 | 215776 | 0.05 | Why? |
| Interferon-gamma | 2 | 2008 | 2711 | 0.05 | Why? |
| Coculture Techniques | 1 | 2021 | 258 | 0.05 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 283 | 0.05 | Why? |
| Heterografts | 1 | 2020 | 203 | 0.05 | Why? |
| Gene Knockout Techniques | 1 | 2021 | 347 | 0.05 | Why? |
| Protein Conformation, beta-Strand | 1 | 2021 | 414 | 0.05 | Why? |
| Antiviral Agents | 3 | 2020 | 41703 | 0.05 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.05 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2021 | 530 | 0.05 | Why? |
| Binding Sites, Antibody | 1 | 2020 | 466 | 0.05 | Why? |
| Genes, Viral | 1 | 2005 | 1428 | 0.05 | Why? |
| Cell Communication | 1 | 2021 | 396 | 0.05 | Why? |
| Epitopes | 2 | 2021 | 4113 | 0.05 | Why? |
| Electroporation | 1 | 2017 | 52 | 0.04 | Why? |
| Binding Sites | 2 | 2021 | 6201 | 0.04 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.04 | Why? |
| Recombination, Genetic | 1 | 2005 | 1265 | 0.04 | Why? |
| Peptidyl-Dipeptidase A | 4 | 2020 | 9659 | 0.04 | Why? |
| Genetic Vectors | 1 | 2005 | 1600 | 0.04 | Why? |
| Gene Editing | 1 | 2021 | 330 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2021 | 1236 | 0.04 | Why? |
| Endosomes | 1 | 2020 | 490 | 0.04 | Why? |
| Phylogeography | 1 | 2021 | 824 | 0.04 | Why? |
| Clone Cells | 1 | 2017 | 312 | 0.04 | Why? |
| Proteolysis | 1 | 2021 | 751 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2020 | 1027 | 0.04 | Why? |
| Hepatocytes | 1 | 2020 | 549 | 0.04 | Why? |
| Hydrogen-Ion Concentration | 1 | 2020 | 993 | 0.04 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2017 | 325 | 0.04 | Why? |
| Pancreas | 1 | 2020 | 398 | 0.04 | Why? |
| Viral Vaccines | 3 | 2007 | 7560 | 0.04 | Why? |
| Post-Exposure Prophylaxis | 1 | 2020 | 472 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| Antibody Specificity | 1 | 2020 | 1328 | 0.04 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.04 | Why? |
| HLA-DR Antigens | 1 | 2017 | 563 | 0.04 | Why? |
| DNA | 1 | 2020 | 778 | 0.04 | Why? |
| United States | 4 | 2021 | 46150 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2021 | 2134 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| New York | 1 | 2021 | 2488 | 0.03 | Why? |
| Amino Acid Sequence | 2 | 2020 | 6049 | 0.03 | Why? |
| Athletes | 1 | 2021 | 1047 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Viral Tropism | 1 | 2020 | 1329 | 0.03 | Why? |
| Virion | 1 | 2020 | 1444 | 0.03 | Why? |
| CRISPR-Cas Systems | 1 | 2021 | 1397 | 0.03 | Why? |
| Adjuvants, Immunologic | 1 | 2021 | 1709 | 0.03 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.03 | Why? |
| Mice, Inbred BALB C | 3 | 2007 | 5814 | 0.03 | Why? |
| Drug Approval | 1 | 2020 | 1325 | 0.03 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2008 | 5837 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2021 | 3786 | 0.03 | Why? |
| Gene Expression | 1 | 2021 | 3332 | 0.03 | Why? |
| Mice, Inbred C57BL | 1 | 2021 | 5542 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| Myocardium | 1 | 2021 | 2323 | 0.02 | Why? |
| Endothelium, Vascular | 1 | 2020 | 1751 | 0.02 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.02 | Why? |
| Immunization, Secondary | 2 | 2007 | 1649 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2020 | 2585 | 0.02 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2007 | 12361 | 0.02 | Why? |
| Lymphocyte Activation | 1 | 2017 | 2742 | 0.02 | Why? |
| Injections, Intraperitoneal | 1 | 2005 | 69 | 0.02 | Why? |
| Drug Discovery | 1 | 2020 | 3092 | 0.02 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.02 | Why? |
| Liver | 1 | 2020 | 4007 | 0.02 | Why? |
| Combinatorial Chemistry Techniques | 1 | 2004 | 54 | 0.02 | Why? |
| Escherichia coli Proteins | 1 | 2005 | 168 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.02 | Why? |
| Mutagenesis, Site-Directed | 1 | 2005 | 449 | 0.02 | Why? |
| Bacterial Vaccines | 1 | 2005 | 139 | 0.02 | Why? |
| Interleukin-4 | 1 | 2005 | 367 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Injections, Intramuscular | 1 | 2005 | 800 | 0.02 | Why? |
| Microscopy, Electron | 1 | 2005 | 830 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Models, Animal | 1 | 2005 | 788 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2007 | 3198 | 0.01 | Why? |
| Sequence Deletion | 1 | 2005 | 674 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Molecular Structure | 1 | 2004 | 1539 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Base Sequence | 1 | 2007 | 3581 | 0.01 | Why? |
| Cluster Analysis | 1 | 2007 | 3001 | 0.01 | Why? |
| Amino Acid Substitution | 1 | 2005 | 1706 | 0.01 | Why? |
| Immunization Schedule | 1 | 2005 | 1305 | 0.01 | Why? |
| Virulence | 1 | 2005 | 2172 | 0.01 | Why? |
| Administration, Oral | 1 | 2005 | 2340 | 0.01 | Why? |
| Sequence Analysis, DNA | 1 | 2007 | 2830 | 0.01 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Viral Matrix Proteins | 1 | 2004 | 1243 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 13720 | 0.00 | Why? |
| Immunoglobulin G | 1 | 2005 | 21571 | 0.00 | Why? |
| China | 1 | 2007 | 50654 | 0.00 | Why? |
Ho's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(224)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(383)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_